# A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT

> **NCT03866109** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Genenta Science** · enrollment: 27 (estimated)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** Temferon

## Key facts

- **NCT ID:** NCT03866109
- **Lead sponsor:** Genenta Science
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-05
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03866109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03866109, "A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03866109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*